Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatocyte phospholipid membranes are the essential structural and functional boundaries of liver cells, playing a central role in maintaining cellular homeostasis and mediating complex metabolic processes [1]. Composed of a complex bilayer of phospholipids, primarily phosphatidylcholine, these membranes provide the environment for vital transmembrane transporters, receptors, and enzymes involved in detoxification and bile secretion [2]. Damage to these membranes, often precipitated by oxidative stress and subsequent lipid peroxidation, is a key pathological feature of alcoholic and non-alcoholic fatty liver diseases, leading to cellular leakage and impaired liver function [3]. Pharmacological strategies targeting the membrane involve 'hepatoprotective' agents such as polyenylphosphatidylcholine and silymarin, which aim to stabilize the lipid bilayer and restore its structural integrity [4]. By incorporating into the membrane or preventing oxidative damage, these therapies help maintain the activity of membrane-bound proteins and protect hepatocytes from toxic insults, including bile acid-induced injury [5]. [1] Alberts B, et al. Molecular Biology of the Cell. 6th ed. [2] Gundermann KJ, et al. Clin Exp Gastroenterol. 2016;9:105-117. [3] Lieber CS. Semin Liver Dis. 2004;24(3):233-254. [4] Kidd PM. Alt Med Rev. 1996;1(4):258-274. [5] Saller R, et al. Drugs. 2001;61(14):2035-2063.
Drugs targeting this structure primarily act through membrane stabilization and repair. Exogenous polyunsaturated phospholipids are integrated into the damaged hepatocyte bilayer, restoring membrane fluidity, integrity, and the proper function of membrane-bound enzymes and transport systems [2,4]. Additionally, these agents inhibit lipid peroxidation and protect the membrane from oxidative stress and detergent-like bile acid damage [5].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte phospholipid membrane.